- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2023
- Schlagwort
-
Positronen-Emissions-Tomografie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
-
Albert, Nathalie
- DOI
-
10.5282/edoc.32667
- URN
-
urn:nbn:de:bvb:19-326673
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Zhicong
- Albert, Nathalie
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2023
Ähnliche Objekte (12)
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
Predicting IDH genotype in gliomas using FET PET radiomics
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics
Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
Multiple surgical resections for progressive IDH wildtype glioblastoma—is it beneficial?
Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
Predicting IDH genotype in gliomas using FET PET radiomics
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics
Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
Multiple surgical resections for progressive IDH wildtype glioblastoma—is it beneficial?
Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
Predicting IDH genotype in gliomas using FET PET radiomics
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics
Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
Multiple surgical resections for progressive IDH wildtype glioblastoma—is it beneficial?
Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients